Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study evaluates the administration of beta-lactam antibiotics in extended infusion in
hematological patients with febrile neutropenia after 5 days of treatment. The beta-lactam
antibiotics analyzed are the following: piperacillin-tazobactam, cefepime and meropenem. Half
of patients will receive the antibiotic in intermittent infusion, while the other half will
receive it in extended infusion.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Universitari de Bellvitge
Collaborators:
Institut d'Investigació Biomèdica de Bellvitge Instituto de Salud Carlos III